BioCentury | Jul 25, 2011
Clinical News

ATH012: Phase IIa started

...it after completing the trial. Advancell Advanced In Vitro Cell Technologies S.A. , Barcelona, Spain Neurotec Pharma S.L....
Items per page:
1 - 1 of 1
BioCentury | Jul 25, 2011
Clinical News

ATH012: Phase IIa started

...it after completing the trial. Advancell Advanced In Vitro Cell Technologies S.A. , Barcelona, Spain Neurotec Pharma S.L....
Items per page:
1 - 1 of 1